Research advances in application of molecular-targeted therapy for hepatocellular carcinoma
10.3969/j.issn.1001-5256.2016.02.03.045
- VernacularTitle:分子靶向药物治疗肝细胞癌的研究进展
- Author:
Yuan LIANG
1
;
Shiming WANG
;
Zhenming SHI
Author Information
1. Department of General Surgery, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
- Publication Type:Research Article
- Keywords:
carcinoma hepatocellular；drug targeted therapy；review
- From:
Journal of Clinical Hepatology
2016;32(3):601-604
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) greatly threatens human health. In clinical treatment, the therapeutic strategies for HCC are attracting more attention. With the research advances in the pathogenesis of HCC and the rapid development of molecular biology techniques, the therapies with molecular-targeted antitumor drugs for advanced HCC have become a hot research topic, and significant efficacy has been achieved in clinical practice. This article summarizes the research advances in clinical application of molecular-targeted drugs for the treatment of HCC and related issues, discusses the future perspectives of therapeutic strategies, and provides a new direction and reference for the clinical treatment of HCC.
